Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2018 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
[Needs assessment for the establishment of an Oral Therapy Unit].
Bull Cancer. 2023 Feb;110(2):184-192. doi: 10.1016/j.bulcan.2022.10.005. Epub 2022 Nov 18.
Bull Cancer. 2023.
PMID: 36411129
French.
Identification of factors associated with aggressive end-of-life antitumour treatment: retrospective study of 1282 patients with cancer.
Debourdeau P, Belkacémi M, Economos G, Assénat E, Hilgers W, Coussirou J, Kouidri Uzan S, Vasquez L, Debourdeau A, Daures JP, Salas S.
Debourdeau P, et al. Among authors: coussirou j.
BMJ Support Palliat Care. 2020 Nov 5:bmjspcare-2020-002635. doi: 10.1136/bmjspcare-2020-002635. Online ahead of print.
BMJ Support Palliat Care. 2020.
PMID: 33154087
Item in Clipboard
Impact of ferric carboxymaltose on the evolution of hemoglobin and ECOG performance status in iron-deficient patients with solid tumors: a 3-month follow-up retrospective study.
Coussirou J, Debourdeau A, Stancu A, Jean C, Azouza W, Chanet B, De Crozals F, Boustany R, Debourdeau P.
Coussirou J, et al.
Support Care Cancer. 2018 Nov;26(11):3827-3834. doi: 10.1007/s00520-018-4250-x. Epub 2018 May 24.
Support Care Cancer. 2018.
PMID: 29797080
Item in Clipboard
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.
Loret EP, et al. Among authors: coussirou j.
Retrovirology. 2016 Apr 1;13:21. doi: 10.1186/s12977-016-0251-3.
Retrovirology. 2016.
PMID: 27036656
Free PMC article.
Clinical Trial.
Item in Clipboard
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.
Loret EP, et al. Among authors: coussirou j.
Retrovirology. 2016 May 9;13(1):35. doi: 10.1186/s12977-016-0264-y.
Retrovirology. 2016.
PMID: 27160192
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite